Physician profile
Michael Brian Moore
NPI 1558742734
$5,853.64
in general payments reported to CMS, 2019-2025
11 companies · $3,226 in 2025
The $3,226 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $362 · 2022: $1,193 · 2023: $30.16 · 2024: $1,043 · 2025: $3,226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,185 · Food and Beverage: $2,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,185.30 |
| Food and Beverage | $2,113.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,148.67 | 2021-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $1,138.08 | 2025 | Navitor |
| Abiomed | $148.39 | 2025 | |
| Abbvie INC. | $108.39 | 2021 | |
| Medtronic, INC. | $107.06 | 2023-2025 | Penditure, Micra, Invos |
| Ethicon US, LLC | $63.86 | 2025 | Evarrest, Prolene |
| Inspiremd LTD | $33.32 | 2025 | Cguard Prime Carotid Stent System |
| Tactile Systems Technology INC | $31.53 | 2025 | Flexitouch Plus, Nimbl |
| Smith+Nephew, INC. | $27.89 | 2024 | Pico 7 |
| Merck Sharp & Dohme LLC | $24.14 | 2022 | |
| Kestra Medical Technology Services, INC. | $22.31 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.